SECOND OPINION: PHARMA-BACKED REBATE RULE WOULD HIKE SENIOR PREMIUMS, BOOST DRUG COMPANY PROFITS
Big Pharma Wants Implementation of Misguided Policy that Does Nothing to Lower… Read More
Big Pharma Wants Implementation of Misguided Policy that Does Nothing to Lower… Read More
Lawmakers Showcase How Big Pharma’s Patent Abuse Drives Out-of-Control… Read More
U.S. Senate Judiciary Subcommittee Hearing Tuesday Will Build on Momentum for… Read More
Campaign Looks Forward to Working with Administration and Congress to Crack… Read More
U.S. House Oversight & Reform Committee Report Shines Light on Branded… Read More
Brand Name Drug Companies Stick to Business-as-Usual in Third Major Round of… Read More
Pharmaceutical Companies Increase Prices on 32 Brand Name Drugs to Start July… Read More
New Report Reveals “Hidden Hand” Of Brand Name Drug Industry In case you… Read More
Pallone and Maloney Announce Joint Investigation into Massive Price Tag on… Read More
Coverage Highlights Backlash Over Massive Price Tag for Unproven Treatment,… Read More
CEO Sidesteps Big Pharma’s Pricing Practices; Pushes Proposals That Would… Read More
Lawmakers Must Advance Solutions to Lower Drug Prices Washington,… Read More